Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	61.38	186.48	115.55
Graham Fair Price	140.70	4.16	1.73
PEG	-99.42	-0.02	3.49
Price/Book	-15.06	0.75	0.89
Price/Cash Flow	-36.80	-18.81	29.77
Prices/Earnings	-85.90	13.67	-96.97
Price/Sales	-6.95	2.82	3.03
Price/FCF	-36.80	-18.81	29.77
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.91	0.38	0.40
Operating Margin	-20.33	-0.06	-0.05
ROA	513.90	< 0.005	< 0.005
ROE	< 0.005	0.01	502.56
ROIC	-0.01	-0.01	-25.88
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.07	-96.81
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-3.62	-0.12	96.68
EPS QOQ	0.28	6.75	2326.95
FCF QOQ	2.28	-2.37	3.83
Revenue QOQ	< 0.005	-0.07	1419.28
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	127.60	131.39	2.97
Days Sales Outstanding (DSO)	60.11	67.96	13.06
Inventory Turnover	0.71	0.68	-2.88
Debt/Capitalization	0.19	0.19	-1.29
Quick Ratio	0.91	1.06	16.28
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7.61	7.46	-1.95
Cash	1.32	1.50	13.68
Capex	-0.16	-0.02	88.60
Free Cash Flow	0.23	-0.30	31.78
Revenue	2.23	2.00	-10.49
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.55	1.72	10.46
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.26	12.57	22.55
Naive Interpretation	Member

06 - Financial Health · Weak

Rating